Aging is often seen as a natural part of life, but a growing number of scientists and medical professionals argue that it should be classified as a disease. By viewing aging as a pathological process, we can better understand and address the underlying mechanisms that contribute to age-related decline and chronic diseases. This perspective shifts the focus toward treating and potentially reversing the effects of aging, ultimately improving the quality of life for older individuals.
Understanding Senescence and Cellular Aging
At the heart of aging is a process called senescence. Cellular senescence refers to the state in which cells permanently stop dividing but do not die. This phenomenon can be triggered by various factors, including DNA damage, oxidative stress, and the shortening of telomeres—the protective caps at the ends of chromosomes that gradually erode with each cell division.
As cells enter senescence, they undergo significant changes:
- Growth Arrest: Senescent cells cease to proliferate.
- Altered Function: They secrete inflammatory cytokines, growth factors, and proteases, collectively known as the senescence-associated secretory phenotype (SASP).
-
Resistance to Apoptosis: These cells resist programmed cell death, allowing them to persist in the body.
The Case for Redefining Aging as a Disease
The idea of classifying aging as a disease has gained traction among experts in the fields of geroscience and biotechnology. The World Health Organization (WHO) already lists aging under the ICD-11 (International Classification of Diseases) as a contributing factor to diseases, though it is not yet recognized as a standalone disease.
By acknowledging aging as a disease, we open the door to:
- Insurance and research funding for anti-aging interventions
- Accelerated development of pharmaceuticals targeting aging pathways
- Clinical trials focused on delaying or reversing biological aging
In fact, organizations like the American Federation for Aging Research (AFAR) and The Buck Institute for Research on Aging are actively studying ways to intervene in the biological processes of aging using senolytics, mTOR inhibitors, NAD+ boosters, and more.
How Gentera Center for Precision Medicine Approaches Aging
At Gentera Center for Precision Medicine, we recognize that aging is not just a number—it's a biological process that can be measured, tracked, and addressed.
Our comprehensive approach includes:
- Advanced Diagnostics: Using tools like Prenuvo full-body MRI, Cleerly heart scans, and PNOĒ VO₂ Max testing, we identify early markers of dysfunction before symptoms occur.
- Functional Medicine Protocols: Led by specialists like Dr. Adonis, our team provides hormone optimization, anti-inflammatory nutrition, and lifestyle interventions to reduce cellular aging.
- IV Therapy & Peptides: Custom IVs and therapeutic peptides such as BPC-157 and Thymosin Alpha-1 support mitochondrial function, immune health, and tissue repair.
- Gentera’s mission is to help patients not only live longer—but thrive longer—with a personalized, science-backed plan for aging well.
The Future of Longevity Medicine
As research progresses, the prospect of treating aging as a disease becomes more realistic. In 2023, the global anti-aging market was valued at over $68 billion, with continued growth projected as technology and public interest in longevity surge (Grand View Research, 2023). Senolytics, NAD+ boosters, and gene-editing techniques like CRISPR may soon become commonplace in clinical anti-aging protocols.
Ultimately, rethinking aging as a treatable, measurable condition empowers individuals to take control of their healthspan—not just their lifespan.
References:
- Baker, D. J., et al. (2016). Naturally occurring p16Ink4a-positive cells shorten healthy lifespan. Nature, 530(7589), 184–189. https://doi.org/10.1038/nature16932
- Grand View Research. (2023). Anti-aging Market Size, Share & Trends Analysis Report. https://www.grandviewresearch.com/industry-analysis/anti-aging-market
- World Health Organization (WHO). ICD-11 for Mortality and Morbidity Statistics. https://icd.who.int/en
- Campisi, J. (2013). Aging, Cellular Senescence, and Cancer. Annual Review of Physiology, 75, 685–705.
